EI
ALNY icon

Ellevest Inc’s Alnylam Pharmaceuticals ALNY Stock Holding History

Ellevest Inc’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$553K Buy
1,842
+5
+0.3% +$1.51K 0.07% 230
2026
Q1 		$608K Buy
1,837
+974
+113% +$331K 0.08% 173
2025
Q4 		$343K Buy
863
+89
+11% +$39.4K 0.05% 296
2025
Q3 		$353K Sell
774
-18
-2% -$7.33K 0.05% 296
2025
Q2 		$258K Buy
792
+19
+2% +$5.26K 0.04% 329
2025
Q1 		$209K Sell
773
-651
-46% -$167K 0.01% 367
2024
Q4 		$335K Sell
1,424
-450
-24% -$118K 0.02% 286
2024
Q3 		$515K Buy
+1,874
New +$488K 0.03% 208
2024
Q1 		– Sell
-1,348
Closed -$258K – 403
2023
Q4 		$258K Sell
1,348
-68
-5% -$11.6K 0.02% 324
2023
Q3 		$251K Buy
1,416
+56
+4% +$10.7K 0.02% 294
2023
Q2 		$258K Buy
1,360
+491
+57% +$97.3K 0.02% 294
2023
Q1 		$174K Sell
869
-230
-21% -$48.3K 0.01% 341
2022
Q4 		$261K Buy
1,099
+11
+1% +$2.35K 0.02% 256
2022
Q3 		$218K Buy
1,088
+98
+10% +$18.7K 0.02% 258
2022
Q2 		$144K Buy
990
+198
+25% +$28.1K 0.01% 344
2022
Q1 		$129K Sell
792
-153
-16% -$23.3K 0.01% 370
2021
Q4 		$160K Sell
945
-126
-12% -$23.4K 0.01% 320
2021
Q3 		$202K Buy
1,071
+62
+6% +$11.6K 0.02% 274
2021
Q2 		$171K Buy
1,009
+94
+10% +$13.8K 0.02% 289
2021
Q1 		$129K Buy
915
+220
+32% +$33.1K 0.02% 303
2020
Q4 		$90K Buy
695
+135
+24% +$18K 0.01% 330
2020
Q3 		$82K Buy
560
+554
+9,233% +$78.7K 0.01% 303
2020
Q2 		$1K Buy
+6
New +$809 ﹤0.01% 947

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ellevest Inc's ALNY Position: Q2 2026 in Review

Ellevest Inc increased its Alnylam Pharmaceuticals (ALNY) stake by 0.27% in Q2 2026, buying an estimated $1.51K and bringing the position to 1,842 shares worth $553K. The position accounts for 0.07% of the portfolio, ranked #230.

Ellevest Inc first reported a position in ALNY in Q2 2020 and has held it in 23 quarters since. The position peaked at $608K in Q1 2026. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Ellevest Inc held 1,842 shares of Alnylam Pharmaceuticals worth $553K as of Q2 2026.
  • Ellevest Inc bought 5 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $1.51K.
  • Alnylam Pharmaceuticals made up 0.07% of Ellevest Inc's portfolio in Q2 2026, its #230 holding.
  • Ellevest Inc first reported a position in Alnylam Pharmaceuticals in Q2 2020 and has held it in 23 quarters since.
  • Ellevest Inc's Alnylam Pharmaceuticals position peaked at $608K in Q1 2026.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Ellevest Inc's 13F filing for Q2 2026, filed 10 Aug 2026.